Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sarat Susarla

Pediatric Pulmonology Houston, TX Medical Doctor

NPI 1356515829 CMS profile 334234

902 Frostwood Dr, Suite 210, Houston, TX 77024

Open in the dashboard

General payments

$194,144

514 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sarat Susarla of Houston, TX is reported in the CMS Open Payments database as having received $194,144 across 514 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23,180 96
2024 General $20,572 79
2023 General $16,138 94
2022 General $16,649 51
2021 General $27,591 39
2020 General $10,375 23
2019 General $79,639 132

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sarat Susarla
  • Pediatric Pulmonology median
  • Middle half of Pediatric Pulmonology
  • National median

In program year 2025, general payments to Sarat Susarla were reported at $23,180. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.

Show as a table
Year Sarat Susarla Pediatric Pulmonology median Middle half National median
2019 $79,639 $151 $59–$495 $163
2020 $10,375 $107 $34–$339 $114
2021 $27,591 $125 $40–$511 $132
2022 $16,649 $133 $49–$428 $149
2023 $16,138 $138 $44–$494 $160
2024 $20,572 $132 $46–$398 $164
2025 $23,180 $139 $60–$405 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genzyme Corporation $81,350 105 payments
  2. Regeneron Healthcare Solutions, Inc. $51,687 110 payments
  3. AstraZeneca Pharmaceuticals LP $35,039 66 payments
  4. Harmony Biosciences LLC $9,830 59 payments
  5. Jazz Pharmaceuticals Inc. $6,999 40 payments
  6. Teva Pharmaceuticals USA, Inc. $6,548 5 payments
  7. Inspire Medical Systems, Inc. $897 23 payments
  8. Avadel CNS Pharmaceuticals, LLC $356 15 payments
  9. GlaxoSmithKline, LLC. $353 39 payments
  10. Philips Electronics North America Corporation $152 7 payments
  11. Other $933 45 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $144,570 71 payments
  2. Travel and Lodging $24,061 63 payments
  3. Food and Beverage $10,278 362 payments
  4. Consulting Fee $10,161 9 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $4,674 2 payments
  6. Education $400 7 payments
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $65,773 80 payments
  2. DUPIXENT Inflammation And Immunology $50,531 97 payments
  3. FASENRA $34,760 52 payments
  4. DUPIXENT Immunology $15,510 20 payments
  5. XYWAV $6,769 35 payments
  6. ProAir Digihaler $6,548 5 payments
  7. AirDuo RespiClick $6,548 5 payments
  8. ArmonAir Digihaler $6,548 5 payments
  9. WAKIX Narcoplepsy $6,203 20 payments
  10. WAKIX Narcolepsy $3,182 7 payments
  11. Other $4,433 188 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

514 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Pulmonology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record